[Therapy of cardiomyopathies].
The treatment of congestive cardiomyopathy is dependent on clinical findings, reduced ejection fraction and presence of congestion. Diet, digitalis and vasodilator drugs: prazosin or dihydralazine are used in congestive cardiomyopathy class I or II (NYHA). In the presence of congestion diuretics are added, in chronic congestion of the lung nitrate. Congestive cardiomyopathy class III or IV (NYHA) is treated with diet, digitalis and the converting enzyme inhibitor captopril. In the therapy of HOCM or HNCM the calcium antagonist verapamil is now widely used and seems to be replacing the beta-blocker treatment with propranolol. If treatment with beta-blocker and calcium antagonists in patients with HOCM class III or IV (NYHA) ist ineffective surgical therapy is necessary.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000628:therapy*; D004039:Diet, Sodium-Restricted; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004078:Dihydralazine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use; D011217:Practolol / Q000031:analogs & derivatives / Q000627:therapeutic use; D011294:Prenalterol; D013695:Temperance; D014665:Vasodilator Agents / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002301:Cardiac Glycosides; D004232:Diuretics; D009566:Nitrates; D014665:Vasodilator Agents; D004077:Digoxin; D002216:Captopril; D014700:Verapamil; D004074:Digitoxin; D011294:Prenalterol; D004078:Dihydralazine; D011217:Practolol
Therapie der Kardiomyopathien.